Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/21/2000EP1009393A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
06/21/2000EP1009390A1 Prolonged anesthesia in joints and body spaces
06/21/2000EP1009388A1 Sustained release drug delivery devices
06/21/2000EP1009387A1 Stabilized sustained release tramadol formulations
06/21/2000EP1009385A2 Cholesterol lowering composition
06/21/2000EP1009384A1 A method of administering liposomal encapsulated taxane
06/21/2000EP1009383A1 Oral liposomal delivery system
06/21/2000EP1009381A1 Carotenoid microemulsions
06/21/2000EP1009380A1 Method for preparing pharmaceutical formulations
06/21/2000EP1009379A1 Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
06/21/2000EP1009377A1 Medical uses of pyruvates
06/21/2000EP1009368A1 Hair conditioners for treating split ends
06/21/2000EP1009345A1 Skin aging and wound treatment using cell migration agents
06/21/2000EP0785196B1 Polymorphs a and b of 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl) propyl]piperazine
06/21/2000EP0676948B1 Antiplaque, antigingivitis, anticaries oral composition
06/21/2000EP0638073B1 1-piperazino-1,2-dihydroindene derivatives
06/21/2000DE19858789A1 Medicament combination of cerivastatin and fibrate, has additive effect in the treatment of lipid metabolism disorders, e.g. dyslipidemia or atherosclerosis
06/21/2000DE19858779A1 New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer
06/21/2000DE19858593A1 (2-Phenyl-4-(phenylsulfonyl)-oxazol-5-yl)-amine therapeutic agents having 5-HT6 receptor affinity, useful for treating CNS disorders such as psychosis, schizophrenia, depression or Alzheimer's disease
06/21/2000DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors
06/21/2000DE19858253A1 Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden Use of inhibitors of the KQT1 channel for preparing a medicament for the treatment of diseases which are caused by helminths and ectoparasites
06/21/2000CN1257507A Novel triptolide derivatives useful in the treatment of autoimmune diseases
06/21/2000CN1257506A Spiro-quinuclidine derivatives, their preparation and use
06/21/2000CN1257505A Fused dihydropyrans
06/21/2000CN1257504A Salts of aromatic sulphonic acids
06/21/2000CN1257503A 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo (3,2-D] pyrimidine-4-ones
06/21/2000CN1257501A Process for preparing 6-0-monoesters of castanospermine
06/21/2000CN1257500A 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257497A Sulfate salt of an HTV protease inhibitor having an improved oral absorption and bioavailability
06/21/2000CN1257489A Substituted benzopyran derivatives for the treatment of inflammation
06/21/2000CN1257486A Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/21/2000CN1257485A Azacyclooctane and heptane derivatives, their preparation and usein therapy
06/21/2000CN1257483A Substituted isoquinolines as ultra short acting neuromuscular blockers
06/21/2000CN1257482A Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist
06/21/2000CN1257481A Novel pyridine derivatives and pharmaceutical compositions containing them
06/21/2000CN1257478A Nitro-benzamide useful as anti-arrhythmic agent
06/21/2000CN1257477A Metalloproteinase inhibitors
06/21/2000CN1257474A New nitromethyl ketones, process for preparing them and compositions containing them
06/21/2000CN1257431A Chemically and thermally stable norastemizole formulations
06/21/2000CN1257429A Use of low-molecular-weight heparins for preventing and treating cerebral edemas
06/21/2000CN1257428A Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
06/21/2000CN1257427A Method of treating isolated systolic hypertension
06/21/2000CN1257426A Use of fumaric acid derivatives
06/21/2000CN1257425A Gastroretentive controlled release microspheres for improved drug delivery
06/21/2000CN1257424A Composition comprising finely divided, crystalling particles of budesonide
06/21/2000CN1257423A Preparation of powder agglomerates
06/21/2000CN1257422A Solid pharmaceutical preparation
06/21/2000CN1257421A Medicinal aerosol products
06/21/2000CN1257072A Novel 1,2-amylic cycle disulfide, its preparation process and medicinal compoisitions containing same
06/21/2000CN1256942A Medicinal composition for treating cough and preparation process thereof
06/21/2000CN1256928A Skin-cleaning medicine (Jiefuning)
06/21/2000CN1256924A Aikanghua powder for treating cancer
06/21/2000CN1256919A Shuanggan injection and preparation process thereof
06/21/2000CN1256918A Application of lotucine in pharmacy
06/21/2000CN1256917A Method for rasing sow conception, farrowing and surical rate by using vitamin E
06/21/2000CN1256916A 9-cis-retinonic acid and medicinal use of salt and ester thereof
06/21/2000CN1053672C Azasteroid compounds for treating prostatic hypertrophy, their preparation and use
06/21/2000CN1053668C Novel compound, process for preparing same and antitumor agent
06/21/2000CN1053667C Inhibiting photodecomposition of 3-substituted-2-oxindoles
06/21/2000CN1053666C Benzoheterocylic compounds and process for preparing medicated salt thereof
06/21/2000CN1053665C 2,4-diaryl-1,3-dithiolanes, 2,4-diaryl-1,3-dioxolanes, 2,4-diaryl-1,3-oxathiolanes derivant
06/21/2000CN1053662C New tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions containing same
06/21/2000CN1053658C Aminostilbazole derivative and medicine
06/21/2000CN1053657C Didepside phthaleins based internal parasite compositions, novel didepside phthaleins and preparation process thereof
06/21/2000CN1053653C Novel L-threonic acid derivant
06/21/2000CN1053591C Nitroglycerine adhesive plaster and process for preparing same
06/21/2000CN1053586C Ointment for treating scald
06/21/2000CN1053582C Medicine composition for curing cold
06/21/2000CN1053575C Capsule for removing heat from liver and relieving sore-throat and preparing method thereof
06/21/2000CN1053574C Capsule for treating hepatitis
06/21/2000CN1053572C Application of oxidized matrine in preparing medicine for treatment of hapatitis B
06/21/2000CN1053571C Application of proliferation in preparation of medicine for inhibiting smooth muscle cell and restinosis
06/21/2000CN1053570C Pharmaceutical composition of piperidinoalkanol-decongestant combination preparation process
06/21/2000CN1053569C Injectable solution and process for preparing same
06/21/2000CN1053556C Compositions containing 13-alkyl-23-imino derivative of LL-28249 compounds and their use
06/20/2000USRE36744 Nasal administration of benzodiazepine hypnotics
06/20/2000US6077963 Process to produce a protease inhibitor
06/20/2000US6077948 Mediators of chronic allograft rejection (AIF-1) and DNA encoding them
06/20/2000US6077944 Secomacrolides from class of erythromycins and process for their preparation
06/20/2000US6077873 Steroid compounds having contraceptive and anti-osteoporosis activity
06/20/2000US6077872 Use of calcium L-threonate in preventing, inhibiting and curing osteoporosis and rickets
06/20/2000US6077871 Droloxifene pharmaceutical compositions
06/20/2000US6077870 Acetamidobenzamide compounds exhibit strong activity against parkinson's disease
06/20/2000US6077869 Administering a substituted or nonsubstituted biphenyl hydrazides as cyclooxygenase-2 inhibitor to the patient for treatment of inflammation
06/20/2000US6077868 Administering to the animal an effective amount of a conjugated linoleic acid (cla) effective to reduce the activity of cyclooxygenase without gastric irritation side effect
06/20/2000US6077867 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
06/20/2000US6077864 Cyclic sulfone derivatives
06/20/2000US6077862 Virus and cancer treatments
06/20/2000US6077861 Modulators of the large-conductance calcium-activated potassium (bk) channels, therefore, useful in the treatment of ischemic stroke
06/20/2000US6077859 Pyrazoles
06/20/2000US6077857 Heterocyclic compounds containing two amide groups which have hemoregulatory activities, can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infections
06/20/2000US6077856 Hemoregulatory compounds
06/20/2000US6077855 Hemoregulatory compounds
06/20/2000US6077854 Tri-substituted phenyl derivatives and processes for their preparation
06/20/2000US6077852 Administering to the patient suffering from alzheimer's disease a substituted benzothiophene derivative
06/20/2000US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/20/2000US6077849 Administering to a diabetic patient an antidiabetic fused bicyclic heteroaryl compound
06/20/2000US6077848 Benzoylecgonine, ecgonine and ecgonidine derivatives
06/20/2000US6077846 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
1 ... 6297 6298 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 ... 7860